Press Releases Redcare Pharmacy NV

Stocks

RDC

NL0012044747

Drug Retailers

Market Closed - Xetra Other stock markets 18:35:05 11/06/2026 +03			After hours 19:44:55
49.02 ^EUR	+1.57%		48.88	-0.29%

06-04	Index changes yield limited price impact - Hochtief joins the Dax	DP
06-04	REDCARE PHARMACY : Deutsche Bank maintains a Buy rating	ZD

Press Releases

05-08	Redcare Pharmacy : Transcript Earnings Release Call Q1 2026	PU
05-06	Redcare Pharmacy : Zwischenmitteilung Q1 2026	PU
05-06	Redcare Pharmacy : Interim Statement Q1 2026	PU
05-06	Redcare Pharmacy starts 2026 with a strong topline performance and a 58% increase of adj. EBITDA.	EQ
04-28	Change in Redcare Pharmacy’s Managing Board: Dirk Brüse to step down as CCO.	EQ
04-28	Change in Redcare Pharmacy’s Managing Board: Dirk Brüse to step down as CCO.	PU
04-28	Redcare Pharmacy: Dirk Brüse to step down as CCO.	EQ
04-22	Redcare Pharmacy becomes the first pharmacy to use new TI access technology for faster e-prescription processes.	EQ
04-16	Redcare Pharmacy : Supervisory Board Rotation Schedule Updated on 16/04/2026	PU
04-16	Redcare Pharmacy : Remuneration Policy Managing Board Updated on 16/04/2026	PU
04-16	Redcare Pharmacy : 2026 Stock Option Plan (Managing Board) Updated on 16/04/2026	PU
04-16	Redcare Pharmacy's Annual General Meeting 2026: All agenda items approved; Anja Hendel, Max Müller and Peter Schmid von Linstow new members of the Supervisory Board.	EQ
04-08	Redcare Pharmacy in Q1: non-Rx growth rebounds in Germany, while strong Rx growth continues.	EQ
03-12	Redcare Pharmacy : UBS Group AG - Redcare Pharmacy N.V. - Venlo	PU
03-09	Redcare Pharmacy : Transcript Earnings Call FY 2025	PU
03-09	Redcare Pharmacy : Transkript Earnings Call FY 2025 (Englisch)	PU
03-09	Redcare Pharmacy : publishes inaugural Climate Transition Plan with new emissions targets	PU
03-06	Redcare Pharmacy : UBS Group AG - Redcare Pharmacy N.V. - Venlo	PU
03-04	Anja Hendel, Max Müller and Peter Schmid von Linstow to be nominated to the Supervisory Board of Redcare Pharmacy.	EQ
03-04	Redcare Pharmacy : Climate Transition Plan 2025 Updated on 04/03/2026	PU
03-04	Redcare Pharmacy : Geschäftsbericht 2025	PU
03-04	Redcare Pharmacy: Strong growth in 2025 surpassing EUR 1bn in Rx revenue; adj. EBITDA up 72% yoy.	EQ
03-04	Redcare Pharmacy N.V. announces guidance for 2026.	EQ
02-27	Redcare Pharmacy : UBS Group AG - Redcare Pharmacy N.V. - Venlo	PU
02-20	Redcare Pharmacy : UBS Group AG - Redcare Pharmacy N.V. - Venlo	PU